Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy

NCT05009719 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy

Interventions

BIOLOGICAL: Prophylactic Donor lymphocytes infusions
BIOLOGICAL: Preventive Donor lymphocytes infusions

Sponsor

St. Petersburg State Pavlov Medical University